What it sells
Single-use endoscopes.
Business model breakdown
Buyer: who owns the budget?
UnverifiedHospital procurement and department heads (urology, pulmonology, anesthesia, GI, ENT, gynecology) or local distributors.
Trigger: what makes them buy now?
UnverifiedAvoiding reprocessing cost and cross-infection risk of reusable endoscopes (inferred from single-use positioning).
Workflow: what inputs become what output?
Single-use ureteroscopes, bronchoscopes, cystoscopes, duodenoscopes and video laryngoscopes connect to HugeMed imaging processors, replacing reusable scope sterilization; plus disposable baskets, forceps and guidewires.
Economics: what it saves and how it charges
Per-procedure disposable scopes and consumables plus capital imaging processors and pumps (razor/blade); R&D is 25% of sales; capacity over 50,000 units monthly.
Distribution: how it reaches customers
Direct sales network plus local distributors in over 100 countries; NMPA, CE MDR, FDA 510(k), MDSAP, ISO 13485; 10,000+ hospitals claimed.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-03-30 | Series C+ | — | — | news.pedaily.cn |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.